#BEGIN_DRUGCARD DB04375

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C20H25N7O6

# Chemical_IUPAC_Name:
(2R)-2-{[4-({[(6R)-2-amino-5-methyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]formamido}pentanedioic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
5-Methyl-5,6,7,8-Tetrahydrofolic Acid

# HET_ID:
C2F

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C20H25N7O6/c1-27-12(9-23-16-15(27)18(31)26-20(21)25-16)8-22-11-4-2-10(3-5-11)17(30)24-13(19(32)33)6-7-14(28)29/h2-5,12-13,22H,6-9H2,1H3,(H,24,30)(H,28,29)(H,32,33)(H4,21,23,25,26,31)/t12-,13-/m1/s1

# InChI_Key:
InChIKey=ZNOVTXRBGFNYRX-CHWSQXEVSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4375

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
459.4558

# Molecular_Weight_Mono:
459.186631567

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1U1J

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.3

# Predicted_LogS:
-3.1

# Predicted_Water_Solubility:
3.46e-01 g/l

# Primary_Accession_No:
DB04375

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936961

# PubChem_Substance_ID:
46505979

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00804

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CN1[C@H](CNC2=CC=C(C=C2)C(=O)N[C@H](CCC(O)=O)C(O)=O)CNC2=C1C(=O)NC(N)=N2

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:16 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AE000512

# Drug_Target_1_GenBank_ID_Protein:
4981844

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
metE

# Drug_Target_1_Gene_Sequence:
>2205 bp
TCAACTTTCAAATTTTTCCCTCATCTCCTTTGCAAGCGCTACCATGTTTCTGAGCGATGG
AATTACTTCGTCCCAGTTTCTCGTCTTGAGACCGCAGTCGGGATTAATCCAGATCAGCTC
CTTAGGCAGTACCCTGAGAACTCTTTCGACTATTTCCCTCATTTCGTTGATGGAGGGAAC
AGCAGGAGAGTGGATGTCCCAAACACCAACACCGATCTGCTTGATCCATCCCTTGAAATT
TTCAAAGGCAGAAATGATCTCACCTTTACTCCTCGAAGCCTCAATGCTGATCACGTCGAA
CTCCAGCTGGTGGATGTACTCAATTATTTCGTTGAAATCCGAGTAGCACATGTGGGCGTG
GATCTGTGTTTCCGGTCTCGCGTTGGCCGCCAGGTTGAAGGCGTTTATCGCCCATTCGAA
GTACTCAGGCCATTTACTCTTTTTGATGGGTGCTTTTTCTCTGAACGCGGGCTCGTCGAT
CTGCACGATTTTTATTCCCGCCTCTTCCAGATCCTTCACTTCTTCGTTTATCGCAAGGGC
TATCTGGTAGGCTATTTCTCTCTCTGGGATGTCTTCCCTGTAGTAGCTCCAGCTCATGAT
GGTGACGGGTCCTGTGAGCATTCCTTTGACGGGCTTTTCCGTGAGAGACTGAGCGTAGGT
GATTTCTTTGAGCGTCATGGGTTCTGGTCGTGTGACGGTGCCGTATATGATTGGTGGGCG
ATAACACCTCGAACCGTAGGAGAGAACCCAGCCGTTCTGAGTAGTGGCGATGCCGTTCAA
CTTCTCAGCGAAGAACTCAACCATGTCGGTTCTTTCAAACTCACCGTGCACAAGAACGTC
GAGTCCTATTTCTTCCTGAAGTTCTATAGCCTTTTTTATCTGTTCCTTTATGAAAGCTTC
ATATTCTTCTTTGGAAATTTCTCCCTTTCTGTATTTTGATCTCATCTTTCTCACTTCAGG
AGTCTGCGGGAAAGAGCCAATGGTCGTTGTTGGAAAGAGTGGAAGGTTCAGTCTTTCTCT
TTGGATTCTGTCGCGCTCGGTGTATTCTTTCTCCCTTCTGAACGAATCTTCTGGAAGATT
TCTTACCCTCTCAACAGCTTGGAGGTCCACCGCGAAATCTTCAAAAGACACGTTAGGAAG
GTCAAATGTTTTGCCTTCCAGGAAATCTTTCAACATTTTTAGCTCTTCGAGCTTTTCTTT
TGCAAAGGCAAGTTTTTCCTTCAATCCGCCTGGCAGATTGTTTTCCAGTTCCAGAGTCAC
TGGAAGATGAAAGAGTGGGCAGGAATTTGAGATGGCACTCGCACCGAGTTTTTCTACCAG
CGATGCCACCTTTCTGAGATCCACTTTCCAGGGCTGGCGGCCGTTTATCACACCAGCCAC
GAGTTTTTTGTCTTCCGGGAACCCGTGTTTTTCGAGATTTTTCAGATTTTCTTCGTTCGA
AACGAAATCGAAGTGAAGTCTCTTCACCGGAAGGGAGACGCACGCTTCGTAGTCGGAAAC
GCTGTCGTAATAGGTGAAAACAGTCAGTGGAAATTCTGAAAGCTCACGGTACACGTTCAG
TATCAGATCCCAGTGGGCCTTTTCAAGATCGCAGACGAAAGCGGGTTCGTTCACGAGAAT
CTCCTTACAGCCATTTTCCACGAGCTTTTCGAATACTTCTTTGTAAACAGAAACGAGGCT
TTCCAGCAGTTTTTCCATTTGATTTGGTCTTCTGATCCACTCGCCGTTTCTTTTGGAAAG
GTACAGGAAAGTGAAAGGACCTATCACCCACGGTGCTGTTTCTATTCCCTTCGATTTGAA
GAACAGATAATCCTCAAGAGGTTTGTTTTCGAGAAGATAGAACTCTTCGGTTTCTATTTC
CGGAACGAGGTAGTGATAGTTGGTATTGAAGAATTTGGTCATTTCCAGAGCCTTTCCACC
GCGCGCCATATCGAAGTACGTTGAAAGTCCTCTGTACTCACCGAACCTCTCCGGAACTGC
CCCCACCATCACCGCTGTGTCGAGCACAAAGTCGTAGTAGGAAAGTTCGTTTGAAGGAAT
CACATCGACGTTCTTTCTGTAGTTTTCCACCATGTACATTCTGAGTTTGTTCATCTCTTC
CTCGAACTGTTCTTCCGTGATCTTTCCCTTCCAGAAATCCTCCAGAGCCTTTTTGAATTC
CCTCTTTTCTCCTATCTTCGGAAAACCGAACGCGTAAGCCTTCAA

# Drug_Target_1_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_1_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2941

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
85572

# Drug_Target_1_Name:
5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase

# Drug_Target_1_Number_of_Residues:
734

# Drug_Target_1_PDB_ID:
1XR2

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01717	Meth_synt_2
PF08267	Meth_synt_1

# Drug_Target_1_Protein_Sequence:
>5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase
MKAYAFGFPKIGEKREFKKALEDFWKGKITEEQFEEEMNKLRMYMVENYRKNVDVIPSNE
LSYYDFVLDTAVMVGAVPERFGEYRGLSTYFDMARGGKALEMTKFFNTNYHYLVPEIETE
EFYLLENKPLEDYLFFKSKGIETAPWVIGPFTFLYLSKRNGEWIRRPNQMEKLLESLVSV
YKEVFEKLVENGCKEILVNEPAFVCDLEKAHWDLILNVYRELSEFPLTVFTYYDSVSDYE
ACVSLPVKRLHFDFVSNEENLKNLEKHGFPEDKKLVAGVINGRQPWKVDLRKVASLVEKL
GASAISNSCPLFHLPVTLELENNLPGGLKEKLAFAKEKLEELKMLKDFLEGKTFDLPNVS
FEDFAVDLQAVERVRNLPEDSFRREKEYTERDRIQRERLNLPLFPTTTIGSFPQTPEVRK
MRSKYRKGEISKEEYEAFIKEQIKKAIELQEEIGLDVLVHGEFERTDMVEFFAEKLNGIA
TTQNGWVLSYGSRCYRPPIIYGTVTRPEPMTLKEITYAQSLTEKPVKGMLTGPVTIMSWS
YYREDIPEREIAYQIALAINEEVKDLEEAGIKIVQIDEPAFREKAPIKKSKWPEYFEWAI
NAFNLAANARPETQIHAHMCYSDFNEIIEYIHQLEFDVISIEASRSKGEIISAFENFKGW
IKQIGVGVWDIHSPAVPSINEMREIVERVLRVLPKELIWINPDCGLKTRNWDEVIPSLRN
MVALAKEMREKFES

# Drug_Target_1_Reaction:
5-methyltetrahydropteroyltri-L-glutamate + L-homocysteine = tetrahydropteroyltri-L-glutamate + L-methionine

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the transfer of a methyl group from 5- methyltetrahydrofolate to homocysteine resulting in methionine formation

# Drug_Target_1_SwissProt_ID:
Q9X112

# Drug_Target_1_SwissProt_Name:
METE_THEMA

# Drug_Target_1_Synonyms:
Cobalamin-independent methionine synthase
EC 2.1.1.14
Methionine synthase, vitamin-B12 independent isozyme

# Drug_Target_1_Theoretical_pI:
4.97

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB04375
